cbdMD CEO Targets Lower Cash Breakeven as Kava Oasis Launches
cbdMD leadership said it is modeling cash breakeven quarterly revenue in the low-to-mid $6 million range, improved from below $7 million. CEO Ronan Kennedy attributed faster Oasis brand depletions to better distribution partners and investment in sales resources for higher sell-through. The Kava Oasis beverage launched to fill shelf space as retailers pull back amid regulatory uncertainty, while state shipping limits reduced direct-to-consumer revenue by about $150,000.